Lannett Company Inc.: Niacin Extended-release Tablets, Usp, 1,000 Mg, 90-count Bottles
Recall Summary Lannett Company is recalling Niacin Extended-release Tablets, USP, 1,000 mg (90-count bottles) distributed nationwide because the tablets failed to dissolve properly during stability testing, meaning they may not release the medication as intended in the body. This prescription medication was distributed across all U.S. states and the District of Columbia. The recall affects bottles with NDC number 62175-322-46.
- Recalling firm
- Lannett Company Inc.
- Product
- Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
- Reason
- Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-05-27
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/32e57f5e-b3fd-42ad-b009-befe6374fcfa